-
Ibritumomab tiuxetan (pronounced /ɪbrɪˈtuːmoʊmæb taɪˈʌksɛtæn/), sold
under the
trade name Zevalin, is a
monoclonal antibody radioimmunotherapy treatment...
- A
radioligand is a
microscopic particle which consists of a
therapeutic radioactive isotope and the cell-targeting
compound - the ligand. The
ligand is...
-
Monoclonal antibody ibritumomab conjugated with
tiuxetan...
-
yttrium (Y 90)
clivatuzumab tetraxetan (USAN)
yttrium (Y 90)
ibritumomab tiuxetan (INN)
yttrium bromatum yttrium fluoratum yttrium iodide yttrium metalli****...
- Iodine-131-sodium
iodide Hyperthyroidism and
thyroid cancer Yttrium-90-ibritumomab
tiuxetan (Zevalin) and Iodine-131-tositumomab (Bexxar)
Refractory lymphoma 131I-MIBG...
- (131I)
tositumomab V10XX01
Sodium phosphate (32P) V10XX02
Ibritumomab tiuxetan (90Y) V10XX03
Radium (223Ra)
dichloride V10XX04
Lutetium (177Lu) oxodotreotide...
- yttrium-90 (90Y) is used to
label drugs such as
edotreotide and
ibritumomab tiuxetan for the
treatment of
various cancers,
including lymphoma, leukemia, liver...
-
triaminopentacarboxylate scaffold for
metal ions. In
ibritumomab tiuxetan, the
chelator tiuxetan is a
modified version of DTPA
whose carbon backbone contains...
- (levoleucovorin),
Folotyn (pralatexate injection),
Zevalin (ibritumomab
tiuxetan),
Marqibo (vincristine
sulfate LIPOSOME injection),
Beleodaq (belinostat)...
- is not
accessible in
normal cells. 131I
tositumomab and 90Y
ibritumomab tiuxetan were the
first agents of radioimmunotherapy, and they were
approved for...
